journal article·2015-01-27Open access

Dissecting the Molecular Mechanism of Apoptosis during Photothermal Therapy Using Gold Nanoprisms

Marta Pérez-Hernández, Pablo del Pino, Scott G. Mitchell, María Moros, Grazyna Stepien, Beatriz Pelaz, Wolfgang J. Parak, Eva M. Gálvez, Julián Pardo, Jesús M. de la Fuente

ACS Nano· Volume 9· Issue 1

Abstract

The photothermal response of plasmonic nanomaterials can be exploited for a number of biomedical applications in diagnostics (biosensing and optoacoustic imaging) and therapy (drug delivery and photothermal therapy). The most common cellular response to photothermal cancer treatment (ablation of solid tumors) using plasmonic nanomaterials is necrosis, a process that releases intracellular constituents into the extracellular milieu producing detrimental inflammatory responses. Here we report the use of laser-induced photothermal therapy employing gold nanoprisms (NPRs) to specifically induce apoptosis in mouse embryonic fibroblast cells transformed with the SV40 virus. Laser-irradiated "hot" NPRs activate the intrinsic/mitochondrial pathway of apoptosis (programmed cell death), which is mediated by the nuclear-encoded proteins Bak and Bax through the activation of the BH3-only protein Bid. We confirm that an apoptosis mechanism is responsible by showing how the NPR-mediated cell death is dependent on the presence of caspase-9 and caspase-3 proteins. The ability to selectively induce apoptotic cell death and to understand the subsequent mechanisms provides the foundations to predict and optimize NP-based photothermal therapy to treat cancer patients suffering from chemo- and radioresistance.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto Universitario de Nanociencia de Aragón (INA), Universidad de Zaragoza, 50018 Zaragoza, Spain

Aragón Health Research Institute (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009 Zaragoza, Spain

CIC biomaGUNE, Paseo Miramon 182, 20009 San Sebastián, Spain

Faculty of Physics, Philipps-Universität Marburg, 35037 Marburg, Germany

Instituto de Carboquímica, ICB-CSIC, 50018 Zaragoza, Spain

Fundacion ARAID, 50018 Zaragoza, Spain

Instituto de Ciencia de Materiales de Aragón (ICMA), CSIC-Universidad de Zaragoza, C/Pedro Cerbuna 12, 50009 Zaragoza, Spain

Institute NanoBiomedicine and Engineering, Shanghai Jiao Tong University, Dongchuan Road 800, 200240 Shanghai, PR China

Funding

European Commission Directorate-General for Research and Innovation · Alexander von Humboldt-Stiftung · European Social Fund · Ministerio de Ciencia e Innovación · Fundación Agencia Aragonesa para la Investigación y el Desarrollo

References (59)

Show source-provided references
1. Lal S. · Acc. Chem. Res. · 2008 · 41 · 184210.1021/ar800150g ↗
2. Kim J.-W. · Nat. Nanotechnol. · 2009 · 4 · 68810.1038/nnano.2009.231 ↗
3. Huschka R. · ACS Nano · 2012 · 6 · 768110.1021/nn301135w ↗
4. Munoz Javier A. · Langmuir · 2008 · 24 · 1251710.1021/la802448z ↗
5. Boyer D. · Biophys. J. · 2003 · 84 · 24A
6. Baffou G. · ACS Nano · 2012 · 6 · 245210.1021/nn2047586 ↗
7. Bao C. · Small · 2013 · 9 · 6810.1002/smll.201201779 ↗
8. Qin Z. P. · Angew. Chem. Int. Ed. · 2012 · 51 · 435810.1002/anie.201200997 ↗
9. Polo E. · Chem. Commun. · 2013 · 49 · 367610.1039/c3cc39112d ↗
10. Wang L. V. · Science · 2012 · 335 · 145810.1126/science.1216210 ↗
11. Dreaden E. C. · Chem. Soc. Rev. · 2011 · 40 · 339110.1039/c0cs00180e ↗
12. Weissleder R. · Nat. Biotechnol. · 2001 · 19 · 31610.1038/86684 ↗
13. Bardhan R. · Acc. Chem. Res. · 2011 · 44 · 93610.1021/ar200023x ↗
14. Alkilany A. M. · Adv. Drug Deliv Rev. · 2012 · 64 · 19010.1016/j.addr.2011.03.005 ↗
15. Chen J. · Nano Lett. · 2007 · 7 · 131810.1021/nl070345g ↗
16. Baffou G. · Phys. Rev. Lett. · 2010 · 104 · 136805(4)10.1103/PhysRevLett.104.136805 ↗
17. Pelaz B. · Langmuir · 2012 · 28 · 896510.1021/la204712u ↗
18. Bartczak D. · Small · 2012 · 8 · 12210.1002/smll.201101422 ↗
19. Mocan T. · J. Cancer · 2014 · 5 · 67910.7150/jca.9481 ↗
20. Huang X. · J. Biomed. Opt. · 2010 · 15 · 058002(7)
21. Li J.-L. · Biomaterials · 2010 · 31 · 949210.1016/j.biomaterials.2010.08.068 ↗
22. Fernandez Cabada T. · Int. J. Nanomed. · 2012 · 7 · 1511
23. Bhatia S. N. · Cancer Res. · 2009 · 69 · 389210.1158/0008-5472.CAN-09-1299 ↗
24. Lowery A. R. · Int. J. Nanomed. · 2006 · 1 · 14910.2147/nano.2006.1.2.149 ↗
25. Grivennikov S. I. · Cell · 2010 · 140 · 88310.1016/j.cell.2010.01.025 ↗
26. Kerr J. F. · Br. J. Cancer · 1972 · 26 · 23910.1038/bjc.1972.33 ↗
27. Ravichandran K. S. · J. Exp. Med. · 2010 · 207 · 180710.1084/jem.20101157 ↗
28. Obeid M. · Nat. Med. · 2007 · 13 · 5410.1038/nm1523 ↗
29. Groh V. · Proc. Natl. Acad. Sci. U. S. A. · 2005 · 102 · 646110.1073/pnas.0501953102 ↗
30. Turk B. · FEBS Lett. · 2007 · 581 · 276110.1016/j.febslet.2007.05.038 ↗
31. Adams J. M. · Curr. Opin. Immunol. · 2007 · 19 · 48810.1016/j.coi.2007.05.004 ↗
32. Elmore S. · Toxicol. Pathol. · 2007 · 35 · 49510.1080/01926230701320337 ↗
33. Qin Z. · Chem. Soc. Rev. · 2012 · 41 · 119110.1039/C1CS15184C ↗
34. Yuan H. · J. Am. Chem. Soc. · 2012 · 134 · 1135810.1021/ja304180y ↗
35. Moros M. · ACS Nano · 2012 · 6 · 156510.1021/nn204543c ↗
36. Ulbrich K. · Eur. J. Pharm. Biopharm. · 2009 · 71 · 25110.1016/j.ejpb.2008.08.021 ↗
37. Loo C. · Nano Lett. · 2005 · 5 · 70910.1021/nl050127s ↗
38. Day E. S. · Int. J. Nanomed. · 2010 · 5 · 44510.2147/IJN.S10881 ↗
39. Huff T. B. · Nanomedicine · 2007 · 2 · 12510.2217/17435889.2.1.125 ↗
40. Krpetic Z. · Nano Lett. · 2010 · 10 · 454910.1021/nl103142t ↗
41. Gilchrist R. K. · Ann. Surg. · 1957 · 146 · 59610.1097/00000658-195710000-00007 ↗
42. Bae K. H. · ACS Nano · 2012 · 6 · 526610.1021/nn301046w ↗
43. Szymańska Z. · J. Theor. Biol. · 2009 · 259 · 56210.1016/j.jtbi.2009.03.021 ↗
44. Helmbrecht K. · Cell. Proliferation · 2000 · 33 · 34110.1046/j.1365-2184.2000.00189.x ↗
45. Wei M. C. · Science · 2001 · 292 · 72710.1126/science.1059108 ↗
46. Ricci J.-E. · J. Cell Biol. · 2003 · 160 · 6510.1083/jcb.200208089 ↗
47. Li H. · Cell · 1998 · 94 · 49110.1016/S0092-8674(00)81590-1 ↗
48. Ren D. · Science · 2010 · 330 · 139010.1126/science.1190217 ↗
49. Cirman T. · J. Biol. Chem. · 2004 · 279 · 357810.1074/jbc.M308347200 ↗
50. Boya P. · Oncogene · 2008 · 27 · 643410.1038/onc.2008.310 ↗
51. KÅGedal K. · FASEB J. · 2001 · 15 · 159210.1096/fj.00-0708fje ↗
52. Foghsgaard L. · J. Cell Biol. · 2001 · 153 · 99910.1083/jcb.153.5.999 ↗
53. Brunk U. T. · Redox Rep. · 1999 · 4 · 310.1179/135100099101534675 ↗
54. Yuan X.-M. · Proc. Natl. Acad. Sci. U. S. A. · 2002 · 99 · 628610.1073/pnas.092135599 ↗
55. Zang Y. · Cell Death Differ. · 2001 · 8 · 47710.1038/sj.cdd.4400843 ↗
56. Wei M. C. · Science · 2001 · 292 · 72710.1126/science.1059108 ↗
57. Lakhani S. A. · Science · 2006 · 311 · 84710.1126/science.1115035 ↗
58. Pardo J. · J. Cell Biol. · 2004 · 167 · 45710.1083/jcb.200406115 ↗
59. Aporta A. · PLoS One · 2012 · 7 · e4521310.1371/journal.pone.0045213 ↗